000 01158 a2200313 4500
005 20250515180010.0
264 0 _c20090707
008 200907s 0 0 eng d
022 _a1533-4406
040 _aNLM
_beng
_cNLM
100 1 _aKassimatis, Theodoros I
245 0 0 _aRosuvastatin in patients undergoing hemodialysis.
_h[electronic resource]
260 _bThe New England journal of medicine
_cJul 2009
300 _a93; author reply 94-5 p.
_bdigital
500 _aPublication Type: Comment; Letter
650 0 4 _aCardiovascular Diseases
_xmortality
650 0 4 _aDiabetes Complications
650 0 4 _aFluorobenzenes
_xtherapeutic use
650 0 4 _aHumans
650 0 4 _aHydroxymethylglutaryl-CoA Reductase Inhibitors
_xtherapeutic use
650 0 4 _aKidney Failure, Chronic
_xdrug therapy
650 0 4 _aPyrimidines
_xtherapeutic use
650 0 4 _aRenal Dialysis
_xadverse effects
650 0 4 _aRisk Factors
650 0 4 _aRosuvastatin Calcium
650 0 4 _aSulfonamides
_xtherapeutic use
700 1 _aKonstantinopoulos, Panagiotis A
773 0 _tThe New England journal of medicine
_gvol. 361
_gno. 1
_gp. 93; author reply 94-5
999 _c18995081
_d18995081